Topic
Hepatocellular Carcinoma (HCC)
68 Podcasts • 36 Cases • 7 Courses on BackTable
Hear how experienced physicians manage Hepatocellular Carcinoma (HCC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 59 • 12 May 2026
Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.
More on Hepatocellular Carcinoma (HCC)
Loading recent podcasts…
Tumor Board Episode #59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
VI Episode #642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
VI Episode #641
May 5, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
1,100+ listens
VI Episode #639
Apr 30, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy
Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...
20+ listens
VI Episode #644
May 12, 2026
with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
70+ listens
VI Episode #640
May 1, 2026
with Dr. Maarten Smits, Dr. Venkatesh Krishnasamy
When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In...
1,900+ listens
Tumor Board Episode #57
Apr 28, 2026
with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi
Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...
170+ listens
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jun 24, 2025
with Dr. Tyler Sandow, Dr. Nima Kokabi and Dr. Venkatesh Krishnasamy
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jul 1, 2025
with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.